propharma
Aguardando apresentação ou exame de recurso contra o indeferimento de Designação Recebida
Marca Mista depositada no INPI em
20/12/2022 por ProPharma Group Holdings, LLC,
processo nº 501720479, nas classes 35, 42, 44, 45.
O processo não está mais ativo — o nome pode estar livre para novo pedido.
| Número do processo | 501720479 |
|---|
| Situação | Aguardando apresentação ou exame de recurso contra o indeferimento de Designação Recebida |
|---|
| Apresentação | Mista |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 20/12/2022 |
|---|
| Data da concessão | — |
|---|
| Vigência até | 20/12/2032 |
|---|
| Titular | ProPharma Group Holdings, LLC |
|---|
| CNPJ/CPF do titular | — |
|---|
| UF · País | — · US |
|---|
Classes e especificação
Business information and business consulting services, namely, providing business advisory services to identify, screen, and select contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providers, namely, designing the administrative, financial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developing, implementing and evaluating patient care plans; business services, namely, tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for business purposes; maintaining files and records concerning the medical condition of individuals; maintaining personal medical history records and files.;
Providing quality assurance services in the medical, pharmaceutical, and biotechnology fields; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the medical, pharmaceutical, and biotechnology fields; testing, analysis, and evaluation of medical, pharmaceutical, and biotechnology services to assure compliance with industry standards; tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for quality control purposes.;
Consulting services in the medical, pharmaceutical, and biotechnology fields; providing medical and pharmaceutical information services, namely, drug interaction call centers, adverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical information, consultancy and advisory services; health care consulting, namely, aggregating clinical, claims, socioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patients, cohorts of patients, and populations; health care consulting, namely, assessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; providing medical information, consultancy, and advisory services, namely, providing healthcare providers, insurance companies, and healthcare product manufacturers with information and statistics regarding patient medication intake, schedule compliance, and health status.;
Regulatory compliance consulting in the pharmaceutical, biotechnology, and medical fields; regulatory compliance consulting in the fields of drug and device development and manufacturing; tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for legal or regulatory compliance purposes; tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes.;